MedPath

Protembis GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

The PROTEMBO Trial

Not Applicable
Recruiting
Conditions
Severe Aortic Valve Stenosis
First Posted Date
2023-05-24
Last Posted Date
2025-07-31
Lead Sponsor
Protembis GmbH
Target Recruit Count
500
Registration Number
NCT05873816
Locations
🇺🇸

Tucson Medical Center Health, Tucson, Arizona, United States

🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

BayCare Health System / Morton Plant Hospital, Clearwater, Florida, United States

and more 17 locations

The PROTEMBO C Trial

Not Applicable
Completed
Conditions
Valvular Heart Disease
First Posted Date
2020-11-06
Last Posted Date
2025-05-08
Lead Sponsor
Protembis GmbH
Target Recruit Count
64
Registration Number
NCT04618718
Locations
🇩🇪

Krankenhaus der Barmherzigen Brüder Trier, Trier, Rhineland-Palatinate, Germany

🇩🇪

Herzzentrum Leipzig-Universitätsklinik für Kardiologie-Helios, Leipzig, Saxony, Germany

🇩🇪

Universitätsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany

and more 5 locations

The PROTEMBO SF Trial

Not Applicable
Completed
Conditions
Aortic Stenosis
First Posted Date
2017-10-30
Last Posted Date
2018-10-31
Lead Sponsor
Protembis GmbH
Target Recruit Count
5
Registration Number
NCT03325283
Locations
🇮🇪

Department of Cardiology Galway University Hospital and SAOLTA Healthcare Group, Galway, County Galway, Ireland

🇱🇻

Pauls Stradins Clinical University Hospital, Riga, Latvia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.